248 related articles for article (PubMed ID: 32976882)
21. Phenylmethanesulfonyl fluoride pretreatment stabilizes plasma lipidome in lipidomic and metabolomic analysis.
Wang X; Gu X; Song H; Song Q; Gao X; Lu Y; Chen H
Anal Chim Acta; 2015 Sep; 893():77-83. PubMed ID: 26398425
[TBL] [Abstract][Full Text] [Related]
22. Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis.
Jiang T; Dai L; Li P; Zhao J; Wang X; An L; Liu M; Wu S; Wang Y; Peng Y; Sun D; Zheng C; Wang T; Wen X; Cheng Z
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158853. PubMed ID: 33160078
[TBL] [Abstract][Full Text] [Related]
23. UPLC-MS/MS-based Lipidomic Profiles Revealed Aberrant Lipids Associated with Invasiveness of Silent Corticotroph Adenoma.
Wang Z; Guo X; Wang W; Gao L; Bao X; Feng M; Lian W; Zhu H; Xing B
J Clin Endocrinol Metab; 2021 Jan; 106(1):e273-e287. PubMed ID: 33031533
[TBL] [Abstract][Full Text] [Related]
24. Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics.
Li W; Wang X; Zhang X; Gong P; Ding D; Wang N; Wang Z
Lipids Health Dis; 2021 Nov; 20(1):160. PubMed ID: 34774030
[TBL] [Abstract][Full Text] [Related]
25. Triple Negative Breast Cancer Detection Using LC-MS/MS Lipidomic Profiling.
Eghlimi R; Shi X; Hrovat J; Xi B; Gu H
J Proteome Res; 2020 Jun; 19(6):2367-2378. PubMed ID: 32397718
[TBL] [Abstract][Full Text] [Related]
26. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
[TBL] [Abstract][Full Text] [Related]
27. UHPLC-HRMS-based serum untargeted lipidomics: Phosphatidylcholines and sphingomyelins are the main disturbed lipid markers to distinguish colorectal advanced adenoma from cancer.
Chen H; Zhou H; Liang Y; Huang Z; Yang S; Wang X; She Z; Wei Z; Zhang Q
J Pharm Biomed Anal; 2023 Sep; 234():115582. PubMed ID: 37473505
[TBL] [Abstract][Full Text] [Related]
28. Serum untargeted lipidomics by UHPLC-ESI-HRMS aids the biomarker discovery of colorectal adenoma.
Zhou H; Nong Y; Zhu Y; Liang Y; Zhang J; Chen H; Zhu P; Zhang Q
BMC Cancer; 2022 Mar; 22(1):314. PubMed ID: 35331175
[TBL] [Abstract][Full Text] [Related]
29. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive serum lipidomic analyses reveal potential biomarkers for malignant breast cancer: A case-control study.
Cao B; Yang S; Yan L; Li N
Cancer Biomark; 2023; 37(4):289-297. PubMed ID: 37302027
[TBL] [Abstract][Full Text] [Related]
31. [Nontargeted lipidomic analysis of sera from sepsis patients based on ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry].
Wang S; Liang J; Shi H; Xia Y; Li J; Wu W; Wang H; Wu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):346-351. PubMed ID: 35692196
[TBL] [Abstract][Full Text] [Related]
32. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
[TBL] [Abstract][Full Text] [Related]
33. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.
Liu D; Meister M; Zhang S; Vong CI; Wang S; Fang R; Li L; Wang PG; Massion P; Ji X
Respir Res; 2020 Sep; 21(1):242. PubMed ID: 32957957
[TBL] [Abstract][Full Text] [Related]
34. Potential plasma lipid biomarkers in early-stage breast cancer.
Jiang N; Zhang G; Pan L; Yan C; Zhang L; Weng Y; Wang W; Chen X; Yang G
Biotechnol Lett; 2017 Nov; 39(11):1657-1666. PubMed ID: 28828718
[TBL] [Abstract][Full Text] [Related]
35. Serum lipid profiling analysis and potential marker discovery for ovarian cancer based on liquid chromatography-Mass spectrometry.
Wang Y; Wang Y; Chen C; Ren F; Cao R; Wang Y; Han P; Zhang X; Xu C; Liu X; Xu G
J Pharm Biomed Anal; 2021 May; 199():114048. PubMed ID: 33836461
[TBL] [Abstract][Full Text] [Related]
36. Serum Untargeted UHPLC-HRMS-Based Lipidomics to Discover the Potential Biomarker of Colorectal Advanced Adenoma.
Zhu Y; Wang L; Nong Y; Liang Y; Huang Z; Zhu P; Zhang Q
Cancer Manag Res; 2021; 13():8865-8878. PubMed ID: 34858060
[TBL] [Abstract][Full Text] [Related]
37. Four Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting Cervical Cancer.
Sun W; Wang L; Zhao D; Wang P; Li Y; Wang S
Gynecol Obstet Invest; 2018; 83(6):533-539. PubMed ID: 30134241
[TBL] [Abstract][Full Text] [Related]
38. Proteomic Screening for Serum Biomarkers for Cervical Cancer and Their Clinical Significance.
Chen Y; Xiong X; Wang Y; Zhao J; Shi H; Zhang H; Wang Y; Wei Y; Xue W; Zhang J
Med Sci Monit; 2019 Jan; 25():288-297. PubMed ID: 30625128
[TBL] [Abstract][Full Text] [Related]
39. Targeted quantitative lipidomic uncovers lipid biomarkers for predicting the presence of compensated cirrhosis and discriminating decompensated cirrhosis from compensated cirrhosis.
Zeng Y; Zhang L; Zheng Z; Su J; Fu Y; Chen T; Lin K; Liu C; Huang H; Ou Q; Zeng Y
Clin Chem Lab Med; 2024 Feb; 62(3):506-521. PubMed ID: 37924531
[TBL] [Abstract][Full Text] [Related]
40. A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients.
Liu T; Tan Z; Yu J; Peng F; Guo J; Meng W; Chen Y; Rao T; Liu Z; Peng J
Expert Rev Proteomics; 2020 Mar; 17(3):233-242. PubMed ID: 32306783
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
